SlideShare a Scribd company logo
www.kp-morgan.com / info@kp-morgan.com
OECT Summit 12th – 13th March 2014, Berlin, Germany
Two Days Conference
Speakers Include:
Jo Burmester,
Director Global Operations,
PharmaSchool Ltd.
Klaus Beinhauer,
Regional Head Global
Monitoring and Site
Management EU
Kai Langel,
Founder and Director,
eClinical Health
Pieter Proot,
Senior Global Trial Leader,
Novartis.
Pete Chan,
Chief Innovation Advocate,
Tudor Reilly Health
Urban Olsson,
Clinical Development Manager,
AstraZeneca
Philippe Auby,
Divisional Director Paediatrics
and CDC, Lundbeck
Dr Ulrike M. Grimm
Vice President, Global Clinical
Operations, Vifor Pharma
Wolfgang Summa,
Vice President of outcomes
delivery and support, ERT
Michaela Kroeger,
Performance & Metrics Lead,
Global Clinical Operations,
Merck Serono.
Aleksandra Jankielewicz,
Clinical Director, Head Europe
North/Central/East Site
Management & Monitoring,
Abbvie
Sanja Bordessoule,
International Clinical Trial
Manager,
Sanofi
Iva Dumbovic Dubravcic,
Clinical Trial Manager,
Roche
Rosamund Round,
Associate Director Patient
Recruitment, Parexel
International
Lydia Dorrego,
Former Clinical Operations
Director, Spain
Yamin Khan, Executive Vice
President Clinical Development,
Pharm-Olam
Jolanta Bilinska, Head of
Department of International
Cooperation National health
Fund Lodz, International
Alliance of Patients
Organizations chair elect
and President Patient Safety
Foundation Poland.
Chairman: Jo Burmester, Director Global Operations, PharmaSchool Ltd & Editor The Journal of
Clinical Research & GCP
Operational Excellence
in Clinical Trials
Summit
Study Feasibility, Patient
Recruitment Retention and Social
Media in Patient Recruitment
12th
– 13th
March 2014,
Berlin, Germany
GOLD SPONSOR
Silver Sponsor
Be the first to place
your logo here
OECT Summit 12th – 13th March 2014, Berlin, Germany
Two Days Conferencewww.kp-morgan.com / info@kp-morgan.com
Operational Excellence
in Clinical Trials Summit
12th – 13th March 2014,
Berlin, Germany
Topics at a Glance: You should not
miss this annual
opportunity
if you are –
Chiefs, Directors,
Heads, Senior
Manager, Leaders
and Executives from
Clinical Operations, Clinical
Developments/Research, Clinical
Trials, Clinical Program, CPM, Study
and Feasibility Management, Global
Monitoring Operations, International
Clinical Research, Patient Recruitment
& Retention, Medical Operations,
Medical Affairs, Medical Advisors, MSL,
Data Management, Compliance and
Regulatory
A basic fact about clinical trial
research:
“Even though a study may be very
well designed and funded,
it cannot bring a drug to market
without the availability of suitable
subject.“
Got a question?
Contact Mr. Andreas Raab
andreas.raab@kp-morgan.com
Tel:	 +35 31 437 85 75
Web:	www.kp-morgan.com
Study Feasibility
•	 Risk assessment
•	 Operational risk and competitive risk within
study feasibility and site selection
•	 Site Selection and Activation 	
Clinical Project Management –
Communication between sites, CROs &
Patients, Investigators, Clinical Trial Teams
•	 Importance of effective communication
between sponsor - CROs – sites
•	 Establishing long run relations between the
site
Risk/Centralised Monitoring
•	 Effect on quality of the trials
•	 Impact on patient recruitment
Evaluating the Study budgets
•	 Minimizing the unpredictable environment on
budget perspective or business perspective
•	 Minimizing the confusions between sponsors
& physicians/sites/labs
•	 How to stay ahead with study budgets in
competitive environment
KPIs - Speed, Cheap & Quantity
Patient Recruitment and Retention
•	 Future of patient recruitment in 2015 and
beyond
•	 Relationship management in recruitment and
retaining of the patients
•	 How and why current industry is driven by
patients
•	 Site staff motivation
•	 Monitoring plan triggers related to the patient
R&R
•	 How to maximize study participation
Effectiveness Questionnaire and Data
Management
•	 Setting up effective questionnaire and
dividing a study feasibility questionnaire
•	 Privacy and security of personal health
information
Clinical Trial Data Capture – balancing quality,
speed and cost
Clinical Outcome Assessments/ePRO
(electronic Patient-Reported Outcome)
Methods
Successsfully Implementing Global Clinical
Trials using eCOA
Paediatric Clinical Trials: why are they
different?
Outsourcing strategies - Patient recruitment
challenges when studies are outsourced
Implementation of Business Models in Clinical
Trials – Patient Recruitment and Retention
Engagement of Investigators in Business
Models or Clinical Trial protocols
Social Media in Patient Recruitment -
Facebook, blogs, SMS & Advertisement
through Online Communities
•	 What role can social media play in improving
patient enrolment through clinical sites?
•	 Patient attitudes and best practices in the
social media recruitment space
•	 Driving the patients traffics from other
websites, blogs, community sites to Pharma
companies local websites
Digital strategies within the Patient
recruitment and retention
Regulatory/Government Support and
Strategy
Best Models for Site Operations
Latest trend in Clinical Trials and importance
of technology in patient recruitment
•	 Use of Smartphone apps are increasing in
popularity
•	 Testing a cheaper way to do clinical research
•	 How to translate technology/databases
knowledge into identification of patients and
attracting them to clinical trials – current
challenges and opportunities
•	 Involvement of new technology in forecasting
the result of the clinical trials
Patient Recruitment in Emerging countries
and Challenges for Global Trials
•	 Challenges for Global Trials and changing
regulatory environments
•	 Innovative Ideas for Global Patient Recruitment
OECT Summit 12th – 13th March 2014, Berlin, Germany
Two Days Conferencewww.kp-morgan.com / info@kp-morgan.com
Session I 9:15hrs
Risk Based monitoring – Its impact on Patient Recruitment
Jo Burmester, Director Global Operations, PharmaSchool Ltd.
Session II 10:00hrs
Paediatric Clinical Trials: why are they different?
Philippe Auby, Divisional Director Paediatrics and CDC, Lundbeck
•	 New Regulatery Framework
•	 Recruitment Challenges
•	 Case Study: Psychopharmacology Case Studies
10:45hrs Networking Tea & Coffee with Continental
Breakfast
Session III 11:15hrs
How online patient-centric platforms will transform the way
clinical trials are done
Kai Langel, Founder and Director, eClinical Health
Special Feature 12:00hrs
Insight on: Informed consent - it’s role in subject recruitment and
retention Jo Burmester
Interactive Discussion 12:30hrs
•	 How much information should we really be giving patients?
•	 Do we make our protocols too restrictive?
•	 Would you personally take part in a clinical trial?
•	 What are the ethical issues with recruiting patients in developing
countries?
Panellists: Philippe Auby, Rosamund Round, Pieter Proot, Urban Olsson
13:00hrs Complimentary Lunch
Session IV 14:00hrs
Enrolment and Retention in a Large Diabetes Study
Pieter Proot, Senior Global Trial Leader, Novartis
•	 Enrolment challenges & how to manage them
•	 Use of generated data to enhnace enrolment in the study
•	 Retention Strategies
•	 Case Study: Type 2 Diabetes Study(Long-Term)
Session V 14:45hrs
Using online tools to accelerate clinical trial recruitment
Pete Chan, Chief Innovation Advocate, Tudor Reilly Health
•	 Digital trends, the rise of the epatient and a key tipping point in
how patients receive information about clinical trials
•	 How pharmaceutical-sponsored disease awareness and clinical
trial websites can accelerate patient recruitment; lessons from
recent online recruitment programmes in mental health
•	 Advantages of independent online health communities versus
pharma-sponsored sites
•	 How big data can transform the planning and implementation
of clinical trials; highlights from Tudor Reilly Health’s ePatient
InsightsTM analysis in non-small cell lung cancer; how to reach
epatients in a digitally smart way
•	 Case Study: PracticalAlzheimers.com, Hepatitiscnews.com
15:30hrs Networking Tea & Coffee with Bakery Delights
Session VI 16:00hrs
Global Clinical Studies, Patient Recruitment Challenges and
Observations
Urban Olsson, Clinical Development Manager, AstraZeneca
•	 	Clinical Project Management
•	 	Clinical Outcome Assessments/ ePRO methods
•	 	Patient Recruitment in Emerging Countries and Challenges for
Global Trials
Session VII 16:45hrs – Special Feature
Insight on: How and why current industry is driven by patients
Rosamund Round, Associate Director Patient Recruitment,
Parexel International
•	 Changing Environment
•	 Advocacy Group Movement
•	 Online Communities
Session VIII 17:05hrs
Overcoming Challenges in Emerging Markets
Yamin Mo Khan, Executive Vice President Clinical Development,
Pharm-Olam
•	 Should we conduct trials in THEK regions?
•	 Abundance of Patients - A good thing?
•	 Logistical, Legal and Financial Hurdles
Open Discussion Panel 17:35hrs
Closing Remarks by Jo Burmester, Director Global Operations
PharmaSchool Ltd 18:05 hrs
18:10hrs Cocktail Reception
All attendees are welcome to join at the complimentary cocktail
reception. An extended opportunity to network and benchmark.
DAY 1
8.15 - 9.00
Registration/ check in with tea and coffee
Opening Remarks by Chair – Jo Burmester,
Director Global Operations, PharmaSchool Ltd & Editor
The Journal of Clinical Research & GCP
OECT Summit 12th – 13th March 2014, Berlin, Germany
Two Days Conferencewww.kp-morgan.com / info@kp-morgan.com
Session IX 9:15hrs
Clinical Project Management and Sponsor Oversight
Dr Ulrike M. Grimm, Vice President, Global Clinical Operations,
Vifor Pharma
•	 KPI’s-benchmarks-dashboards
•	 Implementation of efficient communication processes
•	 Risk Management
•	 Escalation Process
Session X 10:00hrs
Successsfully Implementing Global Clinical Trials using eCOA
Wolfgang Summa, Vice President of outcomes delivery and
support, ERT
•	 Collecting your eCOA data on a Global Scale
•	 Picking the right technology solution for your trial based on
Ptaient population, IT infrastructure of participating countries,
validation status of used instruments(Linguistic and Modality)
•	 	Global Support: Translations/Linguistic validation, Submission of
Ethics committees, Logistics / Hardware, Training, Helpdesk
10:45hrs Networking Coffee Break With Continental
Breakfast
Session XI 11:15hrs
KPI’s – Speed, Cheap & Quality
Michaela Kroeger, Performance & Metrics Lead, Global Clinical
Operations, Merck Serono
Session XII 12:00hrs
Improving Clinical Study Site Productivity
Aleksandra Jankielewicz, Clinical Director, Head Europe North/
Central/East Site Management & Monitoring, Abbvie
Interactive Panel Discussion 12:45hrs
•	 Will Risk Based Monitoring be good or bad for patient
recruitment?
•	 Is it ethical to use social media to recruit patients?
•	 How can we get the balance between encouraging recruitment
and coercing patients or encouraging fraud?
•	 Why do patients withdraw from clinical trials?
Panellists: Ulrike Grimm, Aleksandra Jankeilewicz, Pete Chan
13:15hrs Complimentary Lunch
Session XIII 14:15hrs
Future of Patient Recruitment: Meeting the needs of Patient
Rosamund Round, Associate Director Patient Recruitment,
Parexel International
•	 Embracing Technology
•	 Enhancing communication
•	 Exploring other industries
Session XIV 15:00hrs
Title: Clinical Development Plan
Former Clinical Operations Director, Spain
15:45hrs Networking Coffee Break With Bakery Delights
Session XV 16:15hrs
Patient Empowerment in Clinical Trials
Jolanta Ewa Bilinska, Head of Dept. Int. Cooperation health Fund
Lodz, International Alliance of Patients Organizations
•	 Mission and Vision of IAPO - how to empower patients
•	 The proper information for patients about clinical trials
•	 How to raise awareness about clinical trials
Special Feature 16:45hrs
Open Round Table Discussion to summarize the information
learned through out the 2 days conference to raise final
questions and comments.
Closing Remarks 17:10hrs
Jo Burmester, Director Global Operations PharmaSchool Ltd
17:30hrs Cocktail Reception
All attendees are welcome to join at the complimentary cocktail
reception. An extended opportunity to network and benchmark.
DAY 2
8.15 - 9.00
Registration/ check in with tea and coffee
Opening Remarks by Chair – Jo Burmester
OECT Summit 12th – 13th March 2014, Berlin, Germany
Two Days Conferencewww.kp-morgan.com / info@kp-morgan.com
Patient recruitment and retention offer major challenges to
the clinical researcher with potential for significant impact on
timelines, budgets, and ultimately the scientific integrity of the
trial itself. Many factors affect the recruitment of patients and
difficulty in finding suitable patients is driving the develop-
ment of many innovative methods for accessing new patient
groups. The rise of social media means that new technolo-
gies and changing strategies for communication can be used
to great effect to reach out to patients directly and through
special interest groups, and to communicate with patients
enrolled in clinical trials. How to maximise the benefit of this
approach and ensure our regulatory obligations are appropri-
ately met will be the subject of several sessions during the
summit. Conducting trials in developing countries is becom-
ing more common, because of the potential for large numbers
of treatment naive patients and the willingness of healthcare
staff to learn about clinical research and work with sponsors.
There are, of course, challenges with this approach and dur-
ing the conference there will be opportunities to discuss the
advantages and obstacles, and hear from colleagues working
in these areas. Feasibility studies conducted before a clinical
trial commences can identify risks associated with the trial in
terms of patient recruitment and retention. Also the increasing
emphasis of certain Regulatory Agencies on Risk Assessment
and Risk Based Monitoring can serve to focus our attention on
identifying risks to patient recruitment and therefore develop
strategies to mitigate those risks. There will be sessions during
the summit looking at getting feasibility right, performing risk
assessment in a constructive way and considering the impact
of on-site monitoring on patient recruitment and retention
rates, and how to use this information in a risk based monitor-
ing setting.
A word from the chair
Jo Burmester, Director Global Operations PharmaSchool Ltd and Editor The Journal of
Clinical Research & GCP:
I am very pleased to be involved with this summit on an increasingly important area in
the conduct of clinical trials. The development of new medicines can only continue
if we can recruit patients to our trials and then keep them on board. In my time in the
industry, working with pharmaceutical and biotechnology companies, CROs and non-
commercial researchers, I have seen a dramatic rise in the regulation of clinical trials
and also in public awareness of the advantages and risks of taking part in research as
a patient. These changes offer challenges and opportunities which I look forward to
exploring during the summit.
Conference Benefits:
Opportunity to meet top expert and decision makers from Pharma, Biotech and CRO
industry under one roof.
Venue Berlin
A rewarding opportunity to visit Berlin, Germany
Berlin is a world city of culture, politics, media,
and science. Its economy is primarily based
on high-tech industries and the service sector,
encompassing a diverse range of creative
industries, research facilities, media corporations,
and convention venues. Berlin also serves
as a continental hub for air and rail transport
and is a popular tourist destination. Significant
industries include IT, pharmaceuticals, biomedical
engineering, biotechnology, electronics, traffic
engineering, and renewable energy. Berlin is
home to renowned universities, research institutes,
orchestras, museums, and celebrities and is host
to many sporting events.
Overview
Two Days Conferencewww.kp-morgan.com / info@kp-morgan.com
Registration Form/ Sales Contract
OECT Summit, Berlin, Germany
Organisation Details
	 Company name:
	Address:
	Postcode:
	Country:
	Phone:
	 VAT Number:
Date: Signat.:
Payment terms: After completion and return of the
registration form, full payment is required within 5 days
from receipt of invoice. Entry may be refuse to dele-
gates who have not paid their invoice in full. A credit
card guarantee may be requested if payment has not
been received in full before the event. There is a 50%
liability on all bookings once made, by fax or email. A
no refund policy exists for cancellation received on or
after one month before the event. Should you decide
to cancel after this date the full invoice must be paid.
However, if you cannot attend the conference, you may
make a substitution (colleague) at least one week be-
fore first day of the event, as long as we are informed
in writing by email or fax. Name changes and substi-
tutions must be from the same company. KPM Events
reserves the right to alter the conference content, tim-
ing, speakers or venue without notice. The event may
be postponed or cancelled due to unforeseen events
beyond the control of KPM events. (Force Majeure:
meaning any circumstances beyond the control of KPM
events, including without limitations to any Act of God,
governmental restrain, fire, tempest, strike or lock-out
(other than by KPM events own employees or agents),
war or act of terrorism. We strongly advise all our con-
ference clients to take out travel insurance. The confer-
ence fee includes refreshments, lunch and conference
material for the event. This fee does not include travel,
hotel accommodation, transfers or insurance, (which
KPM events strongly recommend you obtain). We may
store and process your information for administrative
and purposes and to better understand your needs
and how we can improve our products and services. In
addition, we may use that information to contact you.
Please complete the registration form in full so that we
can contact you with our best services.
Delegate Details #1
Delegate Details #2
Delegate Details #3
Delegate Details #4
JOBTITLE
JOBTITLE
JOBTITLE
JOBTITLE
NAME
NAME
NAME
NAME
TITLE
TITLE
TITLE
TITLE
E-MAIL
E-MAIL
E-MAIL
E-MAIL
Phone
Phone
Phone
Phone
I´m interested, please inform me.
I agree with Terms and conditions
No, thanks. I will manage it on my own.
Kindly mark tick as appropriate:
Accomodation during the conference:
Terms & Conditions:
2190€
2DayC
onference
Please, issue me an invoice to pay by bank transfer.
I would like to pay by credit card.
Get30%
discount on early bird
registration
before 24t
h
Januray2014
Bookings email: operations@kp-morgan.com

More Related Content

What's hot

SIP-Feedback system College
SIP-Feedback system CollegeSIP-Feedback system College
SIP-Feedback system CollegeShreekanth Dangi
 
Engage, Retain and Collect Data Directly from Patients in Late Phase Studies
Engage, Retain and Collect Data Directly from Patients in Late Phase StudiesEngage, Retain and Collect Data Directly from Patients in Late Phase Studies
Engage, Retain and Collect Data Directly from Patients in Late Phase Studies
John Reites
 
Cordio
CordioCordio
SMi Group's Adaptive Designs in Clinical Trials 2019
SMi Group's Adaptive Designs in Clinical Trials 2019 SMi Group's Adaptive Designs in Clinical Trials 2019
SMi Group's Adaptive Designs in Clinical Trials 2019
Dale Butler
 
Deborah Schaler - EHPR 2015 - Listening, Learning, Improving
Deborah Schaler - EHPR 2015 - Listening, Learning, ImprovingDeborah Schaler - EHPR 2015 - Listening, Learning, Improving
Deborah Schaler - EHPR 2015 - Listening, Learning, ImprovingDeborah Schaler
 
Clinical Trials Summit 2015
Clinical Trials Summit 2015Clinical Trials Summit 2015
Clinical Trials Summit 2015
Deepak Raj (2,000+Connections)
 
Arab Health Congress 2016 - Big Data Brochure
Arab Health Congress 2016 - Big Data Brochure Arab Health Congress 2016 - Big Data Brochure
Arab Health Congress 2016 - Big Data Brochure
Cheryl Prior
 
NI Electronic Care Record - Des O'Loan
NI Electronic Care Record - Des O'LoanNI Electronic Care Record - Des O'Loan
NI Electronic Care Record - Des O'Loanhealthcareisi
 
Webinar - MedRec - A Panel Discussion with Physicians
Webinar - MedRec - A Panel Discussion with PhysiciansWebinar - MedRec - A Panel Discussion with Physicians
Webinar - MedRec - A Panel Discussion with Physicians
Canadian Patient Safety Institute
 
Integrated Health Information to Examine, Empower and Engage
Integrated Health Information to Examine, Empower and EngageIntegrated Health Information to Examine, Empower and Engage
Integrated Health Information to Examine, Empower and Engage
H-Connect Compusoft
 
Move Your Research Out of the Ivory Tower and Impact Health: Translating Earl...
Move Your Research Out of the Ivory Tower and Impact Health: Translating Earl...Move Your Research Out of the Ivory Tower and Impact Health: Translating Earl...
Move Your Research Out of the Ivory Tower and Impact Health: Translating Earl...
CTSI at UCSF
 
Document
DocumentDocument
Document
soumenpatra15
 
Ronan Herlihy on Engaging Clinicians with data on their ordering practices
Ronan Herlihy on Engaging Clinicians with data on their ordering practicesRonan Herlihy on Engaging Clinicians with data on their ordering practices
Ronan Herlihy on Engaging Clinicians with data on their ordering practices
Cirdan
 
7th annual clinical trials summit 2016
7th annual clinical trials summit 20167th annual clinical trials summit 2016
7th annual clinical trials summit 2016
Deepak Raj (2,000+Connections)
 
Using eConsent in Clinical Research to Support Patient Understanding and Welfare
Using eConsent in Clinical Research to Support Patient Understanding and WelfareUsing eConsent in Clinical Research to Support Patient Understanding and Welfare
Using eConsent in Clinical Research to Support Patient Understanding and Welfare
CRF Health
 
eConsent: Five (5) Key Areas of Preparation
eConsent: Five (5) Key Areas of Preparation eConsent: Five (5) Key Areas of Preparation
eConsent: Five (5) Key Areas of Preparation
CRF Health
 
Managing workload better - - online consultations
Managing workload better -  - online consultationsManaging workload better -  - online consultations
Managing workload better - - online consultations
NHS England
 
Racing for results: lessons learnt in improving the efficiency of HIV VL and ...
Racing for results: lessons learnt in improving the efficiency of HIV VL and ...Racing for results: lessons learnt in improving the efficiency of HIV VL and ...
Racing for results: lessons learnt in improving the efficiency of HIV VL and ...
SystemOne
 
Module 13 quality v2
Module 13 quality v2Module 13 quality v2
Module 13 quality v2
OlgaPaterson1
 

What's hot (20)

SIP-Feedback system College
SIP-Feedback system CollegeSIP-Feedback system College
SIP-Feedback system College
 
Engage, Retain and Collect Data Directly from Patients in Late Phase Studies
Engage, Retain and Collect Data Directly from Patients in Late Phase StudiesEngage, Retain and Collect Data Directly from Patients in Late Phase Studies
Engage, Retain and Collect Data Directly from Patients in Late Phase Studies
 
Cordio
CordioCordio
Cordio
 
SMi Group's Adaptive Designs in Clinical Trials 2019
SMi Group's Adaptive Designs in Clinical Trials 2019 SMi Group's Adaptive Designs in Clinical Trials 2019
SMi Group's Adaptive Designs in Clinical Trials 2019
 
Deborah Schaler - EHPR 2015 - Listening, Learning, Improving
Deborah Schaler - EHPR 2015 - Listening, Learning, ImprovingDeborah Schaler - EHPR 2015 - Listening, Learning, Improving
Deborah Schaler - EHPR 2015 - Listening, Learning, Improving
 
Clinical Trials Summit 2015
Clinical Trials Summit 2015Clinical Trials Summit 2015
Clinical Trials Summit 2015
 
Arab Health Congress 2016 - Big Data Brochure
Arab Health Congress 2016 - Big Data Brochure Arab Health Congress 2016 - Big Data Brochure
Arab Health Congress 2016 - Big Data Brochure
 
NI Electronic Care Record - Des O'Loan
NI Electronic Care Record - Des O'LoanNI Electronic Care Record - Des O'Loan
NI Electronic Care Record - Des O'Loan
 
Webinar - MedRec - A Panel Discussion with Physicians
Webinar - MedRec - A Panel Discussion with PhysiciansWebinar - MedRec - A Panel Discussion with Physicians
Webinar - MedRec - A Panel Discussion with Physicians
 
Integrated Health Information to Examine, Empower and Engage
Integrated Health Information to Examine, Empower and EngageIntegrated Health Information to Examine, Empower and Engage
Integrated Health Information to Examine, Empower and Engage
 
Move Your Research Out of the Ivory Tower and Impact Health: Translating Earl...
Move Your Research Out of the Ivory Tower and Impact Health: Translating Earl...Move Your Research Out of the Ivory Tower and Impact Health: Translating Earl...
Move Your Research Out of the Ivory Tower and Impact Health: Translating Earl...
 
Document
DocumentDocument
Document
 
Ronan Herlihy on Engaging Clinicians with data on their ordering practices
Ronan Herlihy on Engaging Clinicians with data on their ordering practicesRonan Herlihy on Engaging Clinicians with data on their ordering practices
Ronan Herlihy on Engaging Clinicians with data on their ordering practices
 
Cost effective healthcare in medical imaging
Cost effective healthcare in medical imagingCost effective healthcare in medical imaging
Cost effective healthcare in medical imaging
 
7th annual clinical trials summit 2016
7th annual clinical trials summit 20167th annual clinical trials summit 2016
7th annual clinical trials summit 2016
 
Using eConsent in Clinical Research to Support Patient Understanding and Welfare
Using eConsent in Clinical Research to Support Patient Understanding and WelfareUsing eConsent in Clinical Research to Support Patient Understanding and Welfare
Using eConsent in Clinical Research to Support Patient Understanding and Welfare
 
eConsent: Five (5) Key Areas of Preparation
eConsent: Five (5) Key Areas of Preparation eConsent: Five (5) Key Areas of Preparation
eConsent: Five (5) Key Areas of Preparation
 
Managing workload better - - online consultations
Managing workload better -  - online consultationsManaging workload better -  - online consultations
Managing workload better - - online consultations
 
Racing for results: lessons learnt in improving the efficiency of HIV VL and ...
Racing for results: lessons learnt in improving the efficiency of HIV VL and ...Racing for results: lessons learnt in improving the efficiency of HIV VL and ...
Racing for results: lessons learnt in improving the efficiency of HIV VL and ...
 
Module 13 quality v2
Module 13 quality v2Module 13 quality v2
Module 13 quality v2
 

Viewers also liked

Aula invertida
Aula invertidaAula invertida
Aula invertida
Lucía Lamagrande Muñoz
 
ロジカルシンキング力養成講座
ロジカルシンキング力養成講座ロジカルシンキング力養成講座
ロジカルシンキング力養成講座Yusuke Kuroda
 
Erika Enlund Social Media portfolio
Erika Enlund Social Media portfolioErika Enlund Social Media portfolio
Erika Enlund Social Media portfolio
Erika Enlund
 
British social realism
British social realismBritish social realism
British social realismreigatemedia
 
Recull de premsa #Figueres - 21/11/2016
Recull de premsa #Figueres - 21/11/2016Recull de premsa #Figueres - 21/11/2016
Recull de premsa #Figueres - 21/11/2016
Ajuntament de Figueres
 
Time is the New Green
Time is the New GreenTime is the New Green
Time is the New Green
Lawgical
 
PythonShutdownWindows
PythonShutdownWindowsPythonShutdownWindows
PythonShutdownWindowsMatt R
 
Sap Simple!
Sap Simple!Sap Simple!
Sap Simple!wendlidl
 
Cultivating Empathy - The Most Important Feature You Can Provide to Your Team...
Cultivating Empathy - The Most Important Feature You Can Provide to Your Team...Cultivating Empathy - The Most Important Feature You Can Provide to Your Team...
Cultivating Empathy - The Most Important Feature You Can Provide to Your Team...
Codemotion
 
Microfeedback - UX Camp Switzerland
Microfeedback - UX Camp SwitzerlandMicrofeedback - UX Camp Switzerland
Microfeedback - UX Camp Switzerland
Julius Dietz
 
共好讀書會_傾聽,不可思議的力量
共好讀書會_傾聽,不可思議的力量共好讀書會_傾聽,不可思議的力量
共好讀書會_傾聽,不可思議的力量
Cho-chi Yang
 
customer oriented selling
customer oriented sellingcustomer oriented selling
customer oriented selling
Priyanka Chowdhury
 

Viewers also liked (16)

Doc2
Doc2Doc2
Doc2
 
Unidad 17
Unidad 17Unidad 17
Unidad 17
 
Aula invertida
Aula invertidaAula invertida
Aula invertida
 
ロジカルシンキング力養成講座
ロジカルシンキング力養成講座ロジカルシンキング力養成講座
ロジカルシンキング力養成講座
 
Erika Enlund Social Media portfolio
Erika Enlund Social Media portfolioErika Enlund Social Media portfolio
Erika Enlund Social Media portfolio
 
Modelo osi
Modelo osiModelo osi
Modelo osi
 
British social realism
British social realismBritish social realism
British social realism
 
Recull de premsa #Figueres - 21/11/2016
Recull de premsa #Figueres - 21/11/2016Recull de premsa #Figueres - 21/11/2016
Recull de premsa #Figueres - 21/11/2016
 
Time is the New Green
Time is the New GreenTime is the New Green
Time is the New Green
 
SL - Real Estate Deck
SL - Real Estate DeckSL - Real Estate Deck
SL - Real Estate Deck
 
PythonShutdownWindows
PythonShutdownWindowsPythonShutdownWindows
PythonShutdownWindows
 
Sap Simple!
Sap Simple!Sap Simple!
Sap Simple!
 
Cultivating Empathy - The Most Important Feature You Can Provide to Your Team...
Cultivating Empathy - The Most Important Feature You Can Provide to Your Team...Cultivating Empathy - The Most Important Feature You Can Provide to Your Team...
Cultivating Empathy - The Most Important Feature You Can Provide to Your Team...
 
Microfeedback - UX Camp Switzerland
Microfeedback - UX Camp SwitzerlandMicrofeedback - UX Camp Switzerland
Microfeedback - UX Camp Switzerland
 
共好讀書會_傾聽,不可思議的力量
共好讀書會_傾聽,不可思議的力量共好讀書會_傾聽,不可思議的力量
共好讀書會_傾聽,不可思議的力量
 
customer oriented selling
customer oriented sellingcustomer oriented selling
customer oriented selling
 

Similar to 2014 Berlin_ Operational Excellence in Clinical Trails

SMi Group's 12th annual Paediatric Clinical Trials 2018
SMi Group's 12th annual Paediatric Clinical Trials 2018SMi Group's 12th annual Paediatric Clinical Trials 2018
SMi Group's 12th annual Paediatric Clinical Trials 2018
Dale Butler
 
Overcoming Patient Engagement Barriers
Overcoming Patient Engagement BarriersOvercoming Patient Engagement Barriers
Overcoming Patient Engagement Barriers
Koray Atalag
 
Respect patient needs
Respect patient needsRespect patient needs
SMi Group's 8th annual Clinical Trial Logistics conference & exhibition
SMi Group's 8th annual Clinical Trial Logistics conference & exhibitionSMi Group's 8th annual Clinical Trial Logistics conference & exhibition
SMi Group's 8th annual Clinical Trial Logistics conference & exhibition
Dale Butler
 
p-186 Orphan drugs and Rare Diseases
p-186 Orphan drugs and Rare Diseasesp-186 Orphan drugs and Rare Diseases
p-186 Orphan drugs and Rare DiseasesKiran Bains
 
SMi Group's 5th annual Orphan Drugs 2016 conference
SMi Group's 5th annual Orphan Drugs 2016 conferenceSMi Group's 5th annual Orphan Drugs 2016 conference
SMi Group's 5th annual Orphan Drugs 2016 conference
Dale Butler
 
Clinical Trials Event , Mansion House, Dublin, 10052018
Clinical Trials Event , Mansion House, Dublin, 10052018Clinical Trials Event , Mansion House, Dublin, 10052018
Clinical Trials Event , Mansion House, Dublin, 10052018
ipposi
 
Aldo Rolfo, National Clinical Development Manager, Genesis Cancer Care, Austr...
Aldo Rolfo, National Clinical Development Manager, Genesis Cancer Care, Austr...Aldo Rolfo, National Clinical Development Manager, Genesis Cancer Care, Austr...
Aldo Rolfo, National Clinical Development Manager, Genesis Cancer Care, Austr...
GenesisCareUK
 
Innovative Hospital Partnership Model for High Quality Patient Clinical Trials
Innovative Hospital Partnership Model for High Quality Patient Clinical TrialsInnovative Hospital Partnership Model for High Quality Patient Clinical Trials
Innovative Hospital Partnership Model for High Quality Patient Clinical Trials
SGS
 
Longenesis_Investors_TechChill.pdf
Longenesis_Investors_TechChill.pdfLongenesis_Investors_TechChill.pdf
Longenesis_Investors_TechChill.pdf
PaoloMalerba9
 
TransCelerate Overview - Clinical Research Access & Information Exchange Ini...
TransCelerate Overview -  Clinical Research Access & Information Exchange Ini...TransCelerate Overview -  Clinical Research Access & Information Exchange Ini...
TransCelerate Overview - Clinical Research Access & Information Exchange Ini...
TransCelerate
 
Initial Medical Policy and Model Coverage Guidelines
Initial Medical Policy and Model Coverage GuidelinesInitial Medical Policy and Model Coverage Guidelines
Initial Medical Policy and Model Coverage Guidelines
Center for Medical Technology Policy
 
National onco venture_introduction_2017_march_v33
National onco venture_introduction_2017_march_v33National onco venture_introduction_2017_march_v33
National onco venture_introduction_2017_march_v33
National OncoVenture
 
Clinical trial recruitment overview
Clinical trial recruitment overviewClinical trial recruitment overview
Clinical trial recruitment overview
Usama Malik
 
Patient-Centered Clinical Trials 2015
Patient-Centered Clinical Trials 2015Patient-Centered Clinical Trials 2015
Patient-Centered Clinical Trials 2015Nassim Azzi, MBA
 
Value of Patient Engagement Technologies
Value of Patient Engagement TechnologiesValue of Patient Engagement Technologies
Value of Patient Engagement Technologies
Kent State University
 

Similar to 2014 Berlin_ Operational Excellence in Clinical Trails (20)

SMi Group's 12th annual Paediatric Clinical Trials 2018
SMi Group's 12th annual Paediatric Clinical Trials 2018SMi Group's 12th annual Paediatric Clinical Trials 2018
SMi Group's 12th annual Paediatric Clinical Trials 2018
 
Overcoming Patient Engagement Barriers
Overcoming Patient Engagement BarriersOvercoming Patient Engagement Barriers
Overcoming Patient Engagement Barriers
 
P 113 geriatric
P 113 geriatricP 113 geriatric
P 113 geriatric
 
Respect patient needs
Respect patient needsRespect patient needs
Respect patient needs
 
SMi Group's 8th annual Clinical Trial Logistics conference & exhibition
SMi Group's 8th annual Clinical Trial Logistics conference & exhibitionSMi Group's 8th annual Clinical Trial Logistics conference & exhibition
SMi Group's 8th annual Clinical Trial Logistics conference & exhibition
 
p-186 Orphan drugs and Rare Diseases
p-186 Orphan drugs and Rare Diseasesp-186 Orphan drugs and Rare Diseases
p-186 Orphan drugs and Rare Diseases
 
SMi Group's 5th annual Orphan Drugs 2016 conference
SMi Group's 5th annual Orphan Drugs 2016 conferenceSMi Group's 5th annual Orphan Drugs 2016 conference
SMi Group's 5th annual Orphan Drugs 2016 conference
 
Clinical Trials Event , Mansion House, Dublin, 10052018
Clinical Trials Event , Mansion House, Dublin, 10052018Clinical Trials Event , Mansion House, Dublin, 10052018
Clinical Trials Event , Mansion House, Dublin, 10052018
 
Aldo Rolfo, National Clinical Development Manager, Genesis Cancer Care, Austr...
Aldo Rolfo, National Clinical Development Manager, Genesis Cancer Care, Austr...Aldo Rolfo, National Clinical Development Manager, Genesis Cancer Care, Austr...
Aldo Rolfo, National Clinical Development Manager, Genesis Cancer Care, Austr...
 
Innovative Hospital Partnership Model for High Quality Patient Clinical Trials
Innovative Hospital Partnership Model for High Quality Patient Clinical TrialsInnovative Hospital Partnership Model for High Quality Patient Clinical Trials
Innovative Hospital Partnership Model for High Quality Patient Clinical Trials
 
116797_BALS182-1
116797_BALS182-1116797_BALS182-1
116797_BALS182-1
 
PCDD – A Roadmap
PCDD – A RoadmapPCDD – A Roadmap
PCDD – A Roadmap
 
PCDD – A Roadmap
PCDD – A RoadmapPCDD – A Roadmap
PCDD – A Roadmap
 
Longenesis_Investors_TechChill.pdf
Longenesis_Investors_TechChill.pdfLongenesis_Investors_TechChill.pdf
Longenesis_Investors_TechChill.pdf
 
TransCelerate Overview - Clinical Research Access & Information Exchange Ini...
TransCelerate Overview -  Clinical Research Access & Information Exchange Ini...TransCelerate Overview -  Clinical Research Access & Information Exchange Ini...
TransCelerate Overview - Clinical Research Access & Information Exchange Ini...
 
Initial Medical Policy and Model Coverage Guidelines
Initial Medical Policy and Model Coverage GuidelinesInitial Medical Policy and Model Coverage Guidelines
Initial Medical Policy and Model Coverage Guidelines
 
National onco venture_introduction_2017_march_v33
National onco venture_introduction_2017_march_v33National onco venture_introduction_2017_march_v33
National onco venture_introduction_2017_march_v33
 
Clinical trial recruitment overview
Clinical trial recruitment overviewClinical trial recruitment overview
Clinical trial recruitment overview
 
Patient-Centered Clinical Trials 2015
Patient-Centered Clinical Trials 2015Patient-Centered Clinical Trials 2015
Patient-Centered Clinical Trials 2015
 
Value of Patient Engagement Technologies
Value of Patient Engagement TechnologiesValue of Patient Engagement Technologies
Value of Patient Engagement Technologies
 

2014 Berlin_ Operational Excellence in Clinical Trails

  • 1. www.kp-morgan.com / info@kp-morgan.com OECT Summit 12th – 13th March 2014, Berlin, Germany Two Days Conference Speakers Include: Jo Burmester, Director Global Operations, PharmaSchool Ltd. Klaus Beinhauer, Regional Head Global Monitoring and Site Management EU Kai Langel, Founder and Director, eClinical Health Pieter Proot, Senior Global Trial Leader, Novartis. Pete Chan, Chief Innovation Advocate, Tudor Reilly Health Urban Olsson, Clinical Development Manager, AstraZeneca Philippe Auby, Divisional Director Paediatrics and CDC, Lundbeck Dr Ulrike M. Grimm Vice President, Global Clinical Operations, Vifor Pharma Wolfgang Summa, Vice President of outcomes delivery and support, ERT Michaela Kroeger, Performance & Metrics Lead, Global Clinical Operations, Merck Serono. Aleksandra Jankielewicz, Clinical Director, Head Europe North/Central/East Site Management & Monitoring, Abbvie Sanja Bordessoule, International Clinical Trial Manager, Sanofi Iva Dumbovic Dubravcic, Clinical Trial Manager, Roche Rosamund Round, Associate Director Patient Recruitment, Parexel International Lydia Dorrego, Former Clinical Operations Director, Spain Yamin Khan, Executive Vice President Clinical Development, Pharm-Olam Jolanta Bilinska, Head of Department of International Cooperation National health Fund Lodz, International Alliance of Patients Organizations chair elect and President Patient Safety Foundation Poland. Chairman: Jo Burmester, Director Global Operations, PharmaSchool Ltd & Editor The Journal of Clinical Research & GCP Operational Excellence in Clinical Trials Summit Study Feasibility, Patient Recruitment Retention and Social Media in Patient Recruitment 12th – 13th March 2014, Berlin, Germany GOLD SPONSOR Silver Sponsor Be the first to place your logo here
  • 2. OECT Summit 12th – 13th March 2014, Berlin, Germany Two Days Conferencewww.kp-morgan.com / info@kp-morgan.com Operational Excellence in Clinical Trials Summit 12th – 13th March 2014, Berlin, Germany Topics at a Glance: You should not miss this annual opportunity if you are – Chiefs, Directors, Heads, Senior Manager, Leaders and Executives from Clinical Operations, Clinical Developments/Research, Clinical Trials, Clinical Program, CPM, Study and Feasibility Management, Global Monitoring Operations, International Clinical Research, Patient Recruitment & Retention, Medical Operations, Medical Affairs, Medical Advisors, MSL, Data Management, Compliance and Regulatory A basic fact about clinical trial research: “Even though a study may be very well designed and funded, it cannot bring a drug to market without the availability of suitable subject.“ Got a question? Contact Mr. Andreas Raab andreas.raab@kp-morgan.com Tel: +35 31 437 85 75 Web: www.kp-morgan.com Study Feasibility • Risk assessment • Operational risk and competitive risk within study feasibility and site selection • Site Selection and Activation Clinical Project Management – Communication between sites, CROs & Patients, Investigators, Clinical Trial Teams • Importance of effective communication between sponsor - CROs – sites • Establishing long run relations between the site Risk/Centralised Monitoring • Effect on quality of the trials • Impact on patient recruitment Evaluating the Study budgets • Minimizing the unpredictable environment on budget perspective or business perspective • Minimizing the confusions between sponsors & physicians/sites/labs • How to stay ahead with study budgets in competitive environment KPIs - Speed, Cheap & Quantity Patient Recruitment and Retention • Future of patient recruitment in 2015 and beyond • Relationship management in recruitment and retaining of the patients • How and why current industry is driven by patients • Site staff motivation • Monitoring plan triggers related to the patient R&R • How to maximize study participation Effectiveness Questionnaire and Data Management • Setting up effective questionnaire and dividing a study feasibility questionnaire • Privacy and security of personal health information Clinical Trial Data Capture – balancing quality, speed and cost Clinical Outcome Assessments/ePRO (electronic Patient-Reported Outcome) Methods Successsfully Implementing Global Clinical Trials using eCOA Paediatric Clinical Trials: why are they different? Outsourcing strategies - Patient recruitment challenges when studies are outsourced Implementation of Business Models in Clinical Trials – Patient Recruitment and Retention Engagement of Investigators in Business Models or Clinical Trial protocols Social Media in Patient Recruitment - Facebook, blogs, SMS & Advertisement through Online Communities • What role can social media play in improving patient enrolment through clinical sites? • Patient attitudes and best practices in the social media recruitment space • Driving the patients traffics from other websites, blogs, community sites to Pharma companies local websites Digital strategies within the Patient recruitment and retention Regulatory/Government Support and Strategy Best Models for Site Operations Latest trend in Clinical Trials and importance of technology in patient recruitment • Use of Smartphone apps are increasing in popularity • Testing a cheaper way to do clinical research • How to translate technology/databases knowledge into identification of patients and attracting them to clinical trials – current challenges and opportunities • Involvement of new technology in forecasting the result of the clinical trials Patient Recruitment in Emerging countries and Challenges for Global Trials • Challenges for Global Trials and changing regulatory environments • Innovative Ideas for Global Patient Recruitment
  • 3. OECT Summit 12th – 13th March 2014, Berlin, Germany Two Days Conferencewww.kp-morgan.com / info@kp-morgan.com Session I 9:15hrs Risk Based monitoring – Its impact on Patient Recruitment Jo Burmester, Director Global Operations, PharmaSchool Ltd. Session II 10:00hrs Paediatric Clinical Trials: why are they different? Philippe Auby, Divisional Director Paediatrics and CDC, Lundbeck • New Regulatery Framework • Recruitment Challenges • Case Study: Psychopharmacology Case Studies 10:45hrs Networking Tea & Coffee with Continental Breakfast Session III 11:15hrs How online patient-centric platforms will transform the way clinical trials are done Kai Langel, Founder and Director, eClinical Health Special Feature 12:00hrs Insight on: Informed consent - it’s role in subject recruitment and retention Jo Burmester Interactive Discussion 12:30hrs • How much information should we really be giving patients? • Do we make our protocols too restrictive? • Would you personally take part in a clinical trial? • What are the ethical issues with recruiting patients in developing countries? Panellists: Philippe Auby, Rosamund Round, Pieter Proot, Urban Olsson 13:00hrs Complimentary Lunch Session IV 14:00hrs Enrolment and Retention in a Large Diabetes Study Pieter Proot, Senior Global Trial Leader, Novartis • Enrolment challenges & how to manage them • Use of generated data to enhnace enrolment in the study • Retention Strategies • Case Study: Type 2 Diabetes Study(Long-Term) Session V 14:45hrs Using online tools to accelerate clinical trial recruitment Pete Chan, Chief Innovation Advocate, Tudor Reilly Health • Digital trends, the rise of the epatient and a key tipping point in how patients receive information about clinical trials • How pharmaceutical-sponsored disease awareness and clinical trial websites can accelerate patient recruitment; lessons from recent online recruitment programmes in mental health • Advantages of independent online health communities versus pharma-sponsored sites • How big data can transform the planning and implementation of clinical trials; highlights from Tudor Reilly Health’s ePatient InsightsTM analysis in non-small cell lung cancer; how to reach epatients in a digitally smart way • Case Study: PracticalAlzheimers.com, Hepatitiscnews.com 15:30hrs Networking Tea & Coffee with Bakery Delights Session VI 16:00hrs Global Clinical Studies, Patient Recruitment Challenges and Observations Urban Olsson, Clinical Development Manager, AstraZeneca • Clinical Project Management • Clinical Outcome Assessments/ ePRO methods • Patient Recruitment in Emerging Countries and Challenges for Global Trials Session VII 16:45hrs – Special Feature Insight on: How and why current industry is driven by patients Rosamund Round, Associate Director Patient Recruitment, Parexel International • Changing Environment • Advocacy Group Movement • Online Communities Session VIII 17:05hrs Overcoming Challenges in Emerging Markets Yamin Mo Khan, Executive Vice President Clinical Development, Pharm-Olam • Should we conduct trials in THEK regions? • Abundance of Patients - A good thing? • Logistical, Legal and Financial Hurdles Open Discussion Panel 17:35hrs Closing Remarks by Jo Burmester, Director Global Operations PharmaSchool Ltd 18:05 hrs 18:10hrs Cocktail Reception All attendees are welcome to join at the complimentary cocktail reception. An extended opportunity to network and benchmark. DAY 1 8.15 - 9.00 Registration/ check in with tea and coffee Opening Remarks by Chair – Jo Burmester, Director Global Operations, PharmaSchool Ltd & Editor The Journal of Clinical Research & GCP
  • 4. OECT Summit 12th – 13th March 2014, Berlin, Germany Two Days Conferencewww.kp-morgan.com / info@kp-morgan.com Session IX 9:15hrs Clinical Project Management and Sponsor Oversight Dr Ulrike M. Grimm, Vice President, Global Clinical Operations, Vifor Pharma • KPI’s-benchmarks-dashboards • Implementation of efficient communication processes • Risk Management • Escalation Process Session X 10:00hrs Successsfully Implementing Global Clinical Trials using eCOA Wolfgang Summa, Vice President of outcomes delivery and support, ERT • Collecting your eCOA data on a Global Scale • Picking the right technology solution for your trial based on Ptaient population, IT infrastructure of participating countries, validation status of used instruments(Linguistic and Modality) • Global Support: Translations/Linguistic validation, Submission of Ethics committees, Logistics / Hardware, Training, Helpdesk 10:45hrs Networking Coffee Break With Continental Breakfast Session XI 11:15hrs KPI’s – Speed, Cheap & Quality Michaela Kroeger, Performance & Metrics Lead, Global Clinical Operations, Merck Serono Session XII 12:00hrs Improving Clinical Study Site Productivity Aleksandra Jankielewicz, Clinical Director, Head Europe North/ Central/East Site Management & Monitoring, Abbvie Interactive Panel Discussion 12:45hrs • Will Risk Based Monitoring be good or bad for patient recruitment? • Is it ethical to use social media to recruit patients? • How can we get the balance between encouraging recruitment and coercing patients or encouraging fraud? • Why do patients withdraw from clinical trials? Panellists: Ulrike Grimm, Aleksandra Jankeilewicz, Pete Chan 13:15hrs Complimentary Lunch Session XIII 14:15hrs Future of Patient Recruitment: Meeting the needs of Patient Rosamund Round, Associate Director Patient Recruitment, Parexel International • Embracing Technology • Enhancing communication • Exploring other industries Session XIV 15:00hrs Title: Clinical Development Plan Former Clinical Operations Director, Spain 15:45hrs Networking Coffee Break With Bakery Delights Session XV 16:15hrs Patient Empowerment in Clinical Trials Jolanta Ewa Bilinska, Head of Dept. Int. Cooperation health Fund Lodz, International Alliance of Patients Organizations • Mission and Vision of IAPO - how to empower patients • The proper information for patients about clinical trials • How to raise awareness about clinical trials Special Feature 16:45hrs Open Round Table Discussion to summarize the information learned through out the 2 days conference to raise final questions and comments. Closing Remarks 17:10hrs Jo Burmester, Director Global Operations PharmaSchool Ltd 17:30hrs Cocktail Reception All attendees are welcome to join at the complimentary cocktail reception. An extended opportunity to network and benchmark. DAY 2 8.15 - 9.00 Registration/ check in with tea and coffee Opening Remarks by Chair – Jo Burmester
  • 5. OECT Summit 12th – 13th March 2014, Berlin, Germany Two Days Conferencewww.kp-morgan.com / info@kp-morgan.com Patient recruitment and retention offer major challenges to the clinical researcher with potential for significant impact on timelines, budgets, and ultimately the scientific integrity of the trial itself. Many factors affect the recruitment of patients and difficulty in finding suitable patients is driving the develop- ment of many innovative methods for accessing new patient groups. The rise of social media means that new technolo- gies and changing strategies for communication can be used to great effect to reach out to patients directly and through special interest groups, and to communicate with patients enrolled in clinical trials. How to maximise the benefit of this approach and ensure our regulatory obligations are appropri- ately met will be the subject of several sessions during the summit. Conducting trials in developing countries is becom- ing more common, because of the potential for large numbers of treatment naive patients and the willingness of healthcare staff to learn about clinical research and work with sponsors. There are, of course, challenges with this approach and dur- ing the conference there will be opportunities to discuss the advantages and obstacles, and hear from colleagues working in these areas. Feasibility studies conducted before a clinical trial commences can identify risks associated with the trial in terms of patient recruitment and retention. Also the increasing emphasis of certain Regulatory Agencies on Risk Assessment and Risk Based Monitoring can serve to focus our attention on identifying risks to patient recruitment and therefore develop strategies to mitigate those risks. There will be sessions during the summit looking at getting feasibility right, performing risk assessment in a constructive way and considering the impact of on-site monitoring on patient recruitment and retention rates, and how to use this information in a risk based monitor- ing setting. A word from the chair Jo Burmester, Director Global Operations PharmaSchool Ltd and Editor The Journal of Clinical Research & GCP: I am very pleased to be involved with this summit on an increasingly important area in the conduct of clinical trials. The development of new medicines can only continue if we can recruit patients to our trials and then keep them on board. In my time in the industry, working with pharmaceutical and biotechnology companies, CROs and non- commercial researchers, I have seen a dramatic rise in the regulation of clinical trials and also in public awareness of the advantages and risks of taking part in research as a patient. These changes offer challenges and opportunities which I look forward to exploring during the summit. Conference Benefits: Opportunity to meet top expert and decision makers from Pharma, Biotech and CRO industry under one roof. Venue Berlin A rewarding opportunity to visit Berlin, Germany Berlin is a world city of culture, politics, media, and science. Its economy is primarily based on high-tech industries and the service sector, encompassing a diverse range of creative industries, research facilities, media corporations, and convention venues. Berlin also serves as a continental hub for air and rail transport and is a popular tourist destination. Significant industries include IT, pharmaceuticals, biomedical engineering, biotechnology, electronics, traffic engineering, and renewable energy. Berlin is home to renowned universities, research institutes, orchestras, museums, and celebrities and is host to many sporting events. Overview
  • 6. Two Days Conferencewww.kp-morgan.com / info@kp-morgan.com Registration Form/ Sales Contract OECT Summit, Berlin, Germany Organisation Details Company name: Address: Postcode: Country: Phone: VAT Number: Date: Signat.: Payment terms: After completion and return of the registration form, full payment is required within 5 days from receipt of invoice. Entry may be refuse to dele- gates who have not paid their invoice in full. A credit card guarantee may be requested if payment has not been received in full before the event. There is a 50% liability on all bookings once made, by fax or email. A no refund policy exists for cancellation received on or after one month before the event. Should you decide to cancel after this date the full invoice must be paid. However, if you cannot attend the conference, you may make a substitution (colleague) at least one week be- fore first day of the event, as long as we are informed in writing by email or fax. Name changes and substi- tutions must be from the same company. KPM Events reserves the right to alter the conference content, tim- ing, speakers or venue without notice. The event may be postponed or cancelled due to unforeseen events beyond the control of KPM events. (Force Majeure: meaning any circumstances beyond the control of KPM events, including without limitations to any Act of God, governmental restrain, fire, tempest, strike or lock-out (other than by KPM events own employees or agents), war or act of terrorism. We strongly advise all our con- ference clients to take out travel insurance. The confer- ence fee includes refreshments, lunch and conference material for the event. This fee does not include travel, hotel accommodation, transfers or insurance, (which KPM events strongly recommend you obtain). We may store and process your information for administrative and purposes and to better understand your needs and how we can improve our products and services. In addition, we may use that information to contact you. Please complete the registration form in full so that we can contact you with our best services. Delegate Details #1 Delegate Details #2 Delegate Details #3 Delegate Details #4 JOBTITLE JOBTITLE JOBTITLE JOBTITLE NAME NAME NAME NAME TITLE TITLE TITLE TITLE E-MAIL E-MAIL E-MAIL E-MAIL Phone Phone Phone Phone I´m interested, please inform me. I agree with Terms and conditions No, thanks. I will manage it on my own. Kindly mark tick as appropriate: Accomodation during the conference: Terms & Conditions: 2190€ 2DayC onference Please, issue me an invoice to pay by bank transfer. I would like to pay by credit card. Get30% discount on early bird registration before 24t h Januray2014 Bookings email: operations@kp-morgan.com